Welcome to the official home of Medtronic Diabetes Google+. We’re thrilled you’ve found us here. Medtronic Diabetes is working with the global community to change the way people manage diabetes. Together, we’re committed to transforming diabetes care by expanding access, integrating care and improving outcomes, so people living with diabetes can enjoy greater freedom and better health.
The focus of our discussion on this page is living with
diabetes and managing it with technology. We share success stories from people
living with diabetes who inspire us and helpful tips for using our products, which
include insulin pumps and continuous glucose monitoring (CGM) systems. From
time to time, we also talk about industry news and Medtronic’s innovations,
such as connected care solutions to provide remote access to diabetes data and
our work toward the development of an artificial pancreas. Your thoughts and
feedback help us to continuously improve our products and services, so we love
hearing from you and encourage you participate.
We do our best to address comments as quickly as possible. However, if you need immediate assistance, our wonderful 24-Hour HelpLine can be reached at 1-800-646-4633.
This account discusses products approved for use in the U.S. and is intended for U.S. residents. Medtronic does not practice medicine and this page (or any social media account) should not be used as medical advice. Always work closely with your healthcare team to manage your diabetes.
Important Safety Information
Medtronic Diabetes insulin infusion pumps,
continuous glucose monitoring systems and associated components are limited to
sale by or on the order of a physician and should only be used under the
direction of a healthcare professional familiar with the risks associated with
the use of these systems. MiniMed 530G with Enlite is intended for the delivery
of insulin and continuous glucose monitoring for the management of diabetes
mellitus by persons 16 years of age or older who require insulin.
Pump therapy is not recommended for
people who are unwilling or unable to perform a minimum of four blood glucose
tests per day. Insulin pumps use rapid-acting insulin. If your insulin delivery
is interrupted for any reason, you must be prepared to replace the missed
The information provided by CGM systems is intended to supplement, not replace, blood glucose information obtained using a home glucose meter. A confirmatory fingerstick is required prior to making adjustments to diabetes therapy. MiniMed 530G with Enlite is not intended to be used directly for preventing or treating hypoglycemia but to suspend insulin delivery when the user is unable to respond to the Threshold Suspend alarm and take measures to prevent or treat hypoglycemia themselves.
Warning: The Threshold Suspend feature will cause the pump to temporarily suspend insulin delivery for two hours when the sensor glucose reaches a set threshold. Under some conditions of use the pump can suspend again resulting in very limited insulin delivery. Prolonged suspension can increase the risk of serious hyperglycemia, ketosis, and ketoacidosis. Before using the Threshold Suspend feature, it is important to read the Threshold Suspend information in the MiniMed 530G System User Guide and discuss proper use of the Threshold Suspend feature with your healthcare provider.